[1]
“ANALYZING OUTCOMES OF MICROBIAL KERATITIS BY USING BCVA (BEST-CORRECTED VISUAL ACUITY)”, Int. Res. J. Pharm., vol. 9, no. 2, pp. 100–104, Feb. 2018, Accessed: Dec. 15, 2025. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/3186